Glucosamine and Chondroitin Joint Plus
Natural health product licensed in Canada
- Licence holder
- Jensens Labs Inc.
- NPN or DIN-HM
- 80082507
- Status
- Active licence
- Licence date
- 19 January 2018
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Lysine Source : Dichlorhydrate de lysine | 50 milligramme | Not calculated |
| Acide L-ascorbique Source : Solanum lycopersicum - fruit | 30 milligramme | Not calculated |
| Collagène hydrolysé Source : Peau de bovin | 1,000 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de crevettes | 500 milligramme | Not calculated |
| Sulfate de chondroïtine Source : Bos taurus - cartilage | 400 milligramme | Not calculated |
| Boswellia serrata Source : Stem bark oleogum resin Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 333 milligramme Potency : 40 % Boswellic acids | 33.3 milligramme | Not calculated |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 1,000 milligramme | Not calculated |
| Acide hyaluronique Source : Gallus gallus - Crête | 40 milligramme | Not calculated |
Non-medicinal ingredients
Gel de silice, Cellulose microcristalline, Phosphate dicalcique, Stéarate de magnésium, Acide stéarique, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve joint pain associated with osteoarthritis of the knee. Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health. Helps to relieve joint pain and swelling associated with osteoarthritis of the knee. Helps support joint health. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps to relieve joint pain associated with osteoarthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience mild gastrointestinal disturbances such as diarrhea, abdominal pain, heartburn, nausea and vomiting. Hypersensitivity (e.g. allergy) has been known to occur. In which case, discontinue use.
- Précautions et mises en garde
Consult a health care practitioner: if symptoms worsen, or prior to use if you are pregnant or breast-feeding; if you have liver or kidney disease or if you have been instructed to follow a low protein diet.
Source
Official Health Canada record, licence 80082507
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.